NovaBridge Biosciences
NBP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001778016
In the last 90 days, NovaBridge Biosciences insiders filed 0 open-market purchases and 4 sales; 49 institutions reported holding it in 13F filings for Q2 2026, worth $48.1M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Superinvestors holding NBP, Q2 2026
1 superinvestor reports holding NovaBridge Biosciences on Form 13F, worth $11.7M in total. Weight is NovaBridge Biosciences's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| HHLR Advisors (Hillhouse)Zhang Lei | 1.4% | 5,980,568 | $11.7M | Unchanged |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of NBP each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2024
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−13.4%)
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−0.7%)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−3.2%)
Q2 2022
1 superinvestor holding at quarter end
- Sold out
- Greenwoods Asset Management
Q1 2022
2 superinvestors holding at quarter end
Q3 2021
1 superinvestor holding at quarter end
- Added
- HHLR Advisors (Hillhouse) (+8.6%)